VIRUS KILLER: Interferon ɑ2b

Interferon ɑ2b has the function of broad-spectrum antiviral effect, it is recommended by the National Health Commission of the People’s Republic of China as an antiviral treatment drug in the Treatment Scheme of Corona Virus Disease, and has been widely used during the outbreak of the virus.

ANKEBIO stands leading position of Interferon ɑ2b products (rDNA origin/trade name: Anterferon) with most complete dosage forms and specifications, certified by GMP and ISO9001.

Anterferon is the first Recombinant Human Interferon ɑ2b for injection licensed by CFDA. This product exerts actions of anti-viral, inhibiting proliferation of tumor cell and regulating immunity. The latter includes enhancing the activities of macrophages, T cells and NK cells. Having undergone clinical trials, ANTERFERON has been proven to be with the best quality because of its higher efficiency, lower side-effect and less neutralizing.

Recombinant Human Interferon α2b (rIFN α2b, rDNA Origin) for Injection

Lyophilized Powder

Specification: 1M IU/Vial; 3M IU/Vial; 5M IU/Vial

Recombinant Human Interferon α2b (rIFN α2b, rDNA Origin) for Injection

Liquid

Specification: 1M IU/Vial; 3M IU/Vial; 5M IU/Vial; 6M IU/Vial

Recombinant Human Interferon α2b (rIFN α2b, rDNA Origin) for Injection

Pre-filled Syringe

Specification: 3M IU/Vial; 5M IU/Vial; 6M IU/Vial

Recombinant Human Interferon α2b (rIFN α2b, rDNA Origin) for topical use

Eye drops

Specification: 1M IU/5ml/bottle; 2M IU/10ml/bottle

Recombinant Human Interferon α2b (rIFN α2b, rDNA Origin) for topical use

Cream

Specification: 1M IU/5g/tube; 2M IU/10g/tube

Recombinant Human Interferon α2b (rIFN α2b, rDNA Origin) for topical use

Suppository

Specification: 100000 IU/pill